Fabrication of PEGylated SPIONs-Loaded Niosome for Codelivery of Paclitaxel and Trastuzumab for Breast Cancer Treatment: In Vivo Study
ACS Applied Bio Materials · 2024
DOI: 10.1021/acsabm.4c00027 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2024. Verfasst von Saeideh Masoumi Godgaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran 1477893855,Iran. Hauptthemen laut MEDLINE: Paclitaxel, Trastuzumab, Breast Neoplasms, Particle Size. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Islamic Azad University, Blekinge Tekniska H?gskola.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran 1477893855,Iran.
- Department of Textile Engineering, Amirkabir University of Technology, Tehran15875-4413,Iran.
ORCID-Profile: Azadeh Asefnejad
Förderung
- Islamic Azad University
- Blekinge Tekniska H?gskola
Zitieren
APA
Masoumi Godgaz, S., Asefnejad, A., & Bahrami, S. H. (2024). Fabrication of PEGylated SPIONs-Loaded Niosome for Codelivery of Paclitaxel and Trastuzumab for Breast Cancer Treatment: In Vivo Study. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.4c00027
Vancouver
Masoumi Godgaz S, Asefnejad A, Bahrami SH. Fabrication of PEGylated SPIONs-Loaded Niosome for Codelivery of Paclitaxel and Trastuzumab for Breast Cancer Treatment: In Vivo Study. ACS Applied Bio Materials. 2024. doi:10.1021/acsabm.4c00027
BibTeX
@article{MasoumiGodgaz2024,
author = {Masoumi Godgaz, Saeideh and Asefnejad, Azadeh and Bahrami, S Hajir},
title = {Fabrication of PEGylated SPIONs-Loaded Niosome for Codelivery of Paclitaxel and Trastuzumab for Breast Cancer Treatment: In Vivo Study},
journal = {ACS Applied Bio Materials},
year = {2024},
doi = {10.1021/acsabm.4c00027}
}
EUVIMED